SUVEN LIFE SCIENCES
Back to Balance Sheet
|
SUVEN LIFE SCIENCES Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹135 Cr | ₹285 Cr | ₹483 Cr | ₹202 Cr | ₹222 Cr |
What is the latest Total Liabilities ratio of SUVEN LIFE SCIENCES ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹135 Cr |
| Mar2024 | ₹285 Cr |
| Mar2023 | ₹483 Cr |
| Mar2022 | ₹202 Cr |
| Mar2021 | ₹222 Cr |
How is Total Liabilities of SUVEN LIFE SCIENCES Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹135 Cr | -52.55 | |
| Mar2024 | ₹285 Cr | -40.99 | |
| Mar2023 | ₹483 Cr | 139.09 | |
| Mar2022 | ₹202 Cr | -9.17 | |
| Mar2021 | ₹222 Cr | - | |
Compare Total Liabilities of peers of SUVEN LIFE SCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUVEN LIFE SCIENCES | ₹3,809.5 Cr | -2.1% | -2.7% | 23.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹412,590.0 Cr | -2% | -6.1% | -6.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹170,577.0 Cr | -0.8% | -0.8% | 8.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹129,301.0 Cr | 0% | 2.7% | 11% | Stock Analytics | |
| CIPLA | ₹120,471.0 Cr | -0.6% | -2.6% | 0.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,660.0 Cr | -1.3% | 0.6% | -6.4% | Stock Analytics | |
SUVEN LIFE SCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUVEN LIFE SCIENCES | -2.1% |
-2.7% |
23.8% |
| SENSEX | -1% |
-1.2% |
7.9% |
You may also like the below Video Courses